Global Anti-Infective Vaccines Market Insights and Forecast to 2028

Publisher Name :
Date: 25-Feb-2022
No. of pages: 116
Inquire Before Buying

Anti-Infective Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anti-Infective Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Inactivated Vaccines

- Conjugate Vaccines

- Live/attenuated Vaccines

Segment by Application

- Bacterial Diseases

- Viral Diseases

By Company

- Emergent BioDefense Operations Lansing Inc.

- Sanofi Pasteur

- Merck & Co.

- MedImmune LLC

- Novartis Vaccines

- Diagnostics Ltd.

- Intercell Biomedical

- MassBiologics

- Barr Labs, Inc.

- Organon Teknika Co.

- GlaxoSmithKline Biologicals

- CSL Ltd.

- ID Biomedical Co.

- Protein Sciences Co.

- Wyeth Pharmaceuticals, Inc.

- Berna Biotech

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Anti-Infective Vaccines Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Anti-Infective Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Infective Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Live/attenuated Vaccines
1.3 Market by Application
1.3.1 Global Anti-Infective Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Bacterial Diseases
1.3.3 Viral Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-Infective Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-Infective Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-Infective Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-Infective Vaccines Sales by Region
2.4.1 Global Anti-Infective Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Anti-Infective Vaccines by Region (2023-2028)
2.5 Global Anti-Infective Vaccines Revenue by Region
2.5.1 Global Anti-Infective Vaccines Revenue by Region (2017-2022)
2.5.2 Global Anti-Infective Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-Infective Vaccines Sales by Manufacturers
3.1.1 Global Top Anti-Infective Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Infective Vaccines in 2021
3.2 Global Anti-Infective Vaccines Revenue by Manufacturers
3.2.1 Global Anti-Infective Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-Infective Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Infective Vaccines Revenue in 2021
3.3 Global Anti-Infective Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-Infective Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-Infective Vaccines Sales by Type
4.1.1 Global Anti-Infective Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Anti-Infective Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-Infective Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Anti-Infective Vaccines Revenue by Type
4.2.1 Global Anti-Infective Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-Infective Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-Infective Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Anti-Infective Vaccines Price by Type
4.3.1 Global Anti-Infective Vaccines Price by Type (2017-2022)
4.3.2 Global Anti-Infective Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-Infective Vaccines Sales by Application
5.1.1 Global Anti-Infective Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Anti-Infective Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-Infective Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Anti-Infective Vaccines Revenue by Application
5.2.1 Global Anti-Infective Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-Infective Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-Infective Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Anti-Infective Vaccines Price by Application
5.3.1 Global Anti-Infective Vaccines Price by Application (2017-2022)
5.3.2 Global Anti-Infective Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-Infective Vaccines Market Size by Type
6.1.1 North America Anti-Infective Vaccines Sales by Type (2017-2028)
6.1.2 North America Anti-Infective Vaccines Revenue by Type (2017-2028)
6.2 North America Anti-Infective Vaccines Market Size by Application
6.2.1 North America Anti-Infective Vaccines Sales by Application (2017-2028)
6.2.2 North America Anti-Infective Vaccines Revenue by Application (2017-2028)
6.3 North America Anti-Infective Vaccines Market Size by Country
6.3.1 North America Anti-Infective Vaccines Sales by Country (2017-2028)
6.3.2 North America Anti-Infective Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-Infective Vaccines Market Size by Type
7.1.1 Europe Anti-Infective Vaccines Sales by Type (2017-2028)
7.1.2 Europe Anti-Infective Vaccines Revenue by Type (2017-2028)
7.2 Europe Anti-Infective Vaccines Market Size by Application
7.2.1 Europe Anti-Infective Vaccines Sales by Application (2017-2028)
7.2.2 Europe Anti-Infective Vaccines Revenue by Application (2017-2028)
7.3 Europe Anti-Infective Vaccines Market Size by Country
7.3.1 Europe Anti-Infective Vaccines Sales by Country (2017-2028)
7.3.2 Europe Anti-Infective Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-Infective Vaccines Market Size by Type
8.1.1 Asia Pacific Anti-Infective Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-Infective Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-Infective Vaccines Market Size by Application
8.2.1 Asia Pacific Anti-Infective Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-Infective Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-Infective Vaccines Market Size by Region
8.3.1 Asia Pacific Anti-Infective Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-Infective Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anti-Infective Vaccines Market Size by Type
9.1.1 Latin America Anti-Infective Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Anti-Infective Vaccines Revenue by Type (2017-2028)
9.2 Latin America Anti-Infective Vaccines Market Size by Application
9.2.1 Latin America Anti-Infective Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Anti-Infective Vaccines Revenue by Application (2017-2028)
9.3 Latin America Anti-Infective Vaccines Market Size by Country
9.3.1 Latin America Anti-Infective Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Anti-Infective Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-Infective Vaccines Market Size by Type
10.1.1 Middle East and Africa Anti-Infective Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-Infective Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-Infective Vaccines Market Size by Application
10.2.1 Middle East and Africa Anti-Infective Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-Infective Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-Infective Vaccines Market Size by Country
10.3.1 Middle East and Africa Anti-Infective Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-Infective Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Emergent BioDefense Operations Lansing Inc.
11.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
11.1.2 Emergent BioDefense Operations Lansing Inc. Overview
11.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Emergent BioDefense Operations Lansing Inc. Recent Developments
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Corporation Information
11.2.2 Sanofi Pasteur Overview
11.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Pasteur Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Pasteur Recent Developments
11.3 Merck & Co.
11.3.1 Merck & Co. Corporation Information
11.3.2 Merck & Co. Overview
11.3.3 Merck & Co. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck & Co. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck & Co. Recent Developments
11.4 MedImmune LLC
11.4.1 MedImmune LLC Corporation Information
11.4.2 MedImmune LLC Overview
11.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MedImmune LLC Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MedImmune LLC Recent Developments
11.5 Novartis Vaccines
11.5.1 Novartis Vaccines Corporation Information
11.5.2 Novartis Vaccines Overview
11.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis Vaccines Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Vaccines Recent Developments
11.6 Diagnostics Ltd.
11.6.1 Diagnostics Ltd. Corporation Information
11.6.2 Diagnostics Ltd. Overview
11.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Diagnostics Ltd. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Diagnostics Ltd. Recent Developments
11.7 Intercell Biomedical
11.7.1 Intercell Biomedical Corporation Information
11.7.2 Intercell Biomedical Overview
11.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Intercell Biomedical Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Intercell Biomedical Recent Developments
11.8 MassBiologics
11.8.1 MassBiologics Corporation Information
11.8.2 MassBiologics Overview
11.8.3 MassBiologics Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 MassBiologics Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 MassBiologics Recent Developments
11.9 Barr Labs, Inc.
11.9.1 Barr Labs, Inc. Corporation Information
11.9.2 Barr Labs, Inc. Overview
11.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Barr Labs, Inc. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Barr Labs, Inc. Recent Developments
11.10 Organon Teknika Co.
11.10.1 Organon Teknika Co. Corporation Information
11.10.2 Organon Teknika Co. Overview
11.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Organon Teknika Co. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Organon Teknika Co. Recent Developments
11.11 GlaxoSmithKline Biologicals
11.11.1 GlaxoSmithKline Biologicals Corporation Information
11.11.2 GlaxoSmithKline Biologicals Overview
11.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 GlaxoSmithKline Biologicals Recent Developments
11.12 CSL Ltd.
11.12.1 CSL Ltd. Corporation Information
11.12.2 CSL Ltd. Overview
11.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 CSL Ltd. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 CSL Ltd. Recent Developments
11.13 ID Biomedical Co.
11.13.1 ID Biomedical Co. Corporation Information
11.13.2 ID Biomedical Co. Overview
11.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 ID Biomedical Co. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 ID Biomedical Co. Recent Developments
11.14 Protein Sciences Co.
11.14.1 Protein Sciences Co. Corporation Information
11.14.2 Protein Sciences Co. Overview
11.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Protein Sciences Co. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Protein Sciences Co. Recent Developments
11.15 Wyeth Pharmaceuticals, Inc.
11.15.1 Wyeth Pharmaceuticals, Inc. Corporation Information
11.15.2 Wyeth Pharmaceuticals, Inc. Overview
11.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Wyeth Pharmaceuticals, Inc. Recent Developments
11.16 Berna Biotech
11.16.1 Berna Biotech Corporation Information
11.16.2 Berna Biotech Overview
11.16.3 Berna Biotech Anti-Infective Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Berna Biotech Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Berna Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-Infective Vaccines Industry Chain Analysis
12.2 Anti-Infective Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Infective Vaccines Production Mode & Process
12.4 Anti-Infective Vaccines Sales and Marketing
12.4.1 Anti-Infective Vaccines Sales Channels
12.4.2 Anti-Infective Vaccines Distributors
12.5 Anti-Infective Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-Infective Vaccines Industry Trends
13.2 Anti-Infective Vaccines Market Drivers
13.3 Anti-Infective Vaccines Market Challenges
13.4 Anti-Infective Vaccines Market Restraints
14 Key Findings in The Global Anti-Infective Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Anti-Infective Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Inactivated Vaccines
Table 3. Major Manufacturers of Conjugate Vaccines
Table 4. Major Manufacturers of Live/attenuated Vaccines
Table 5. Global Anti-Infective Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Anti-Infective Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Anti-Infective Vaccines Sales by Region (2017-2022) & (Units)
Table 8. Global Anti-Infective Vaccines Sales Market Share by Region (2017-2022)
Table 9. Global Anti-Infective Vaccines Sales by Region (2023-2028) & (Units)
Table 10. Global Anti-Infective Vaccines Sales Market Share by Region (2023-2028)
Table 11. Global Anti-Infective Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Anti-Infective Vaccines Revenue Market Share by Region (2017-2022)
Table 13. Global Anti-Infective Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Anti-Infective Vaccines Revenue Market Share by Region (2023-2028)
Table 15. Global Anti-Infective Vaccines Sales by Manufacturers (2017-2022) & (Units)
Table 16. Global Anti-Infective Vaccines Sales Share by Manufacturers (2017-2022)
Table 17. Global Anti-Infective Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Anti-Infective Vaccines Revenue Share by Manufacturers (2017-2022)
Table 19. Anti-Infective Vaccines Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Anti-Infective Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Vaccines as of 2021)
Table 22. Anti-Infective Vaccines Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Anti-Infective Vaccines Product Offered
Table 24. Date of Manufacturers Enter into Anti-Infective Vaccines Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)
Table 27. Global Anti-Infective Vaccines Sales by Type (2023-2028) & (Units)
Table 28. Global Anti-Infective Vaccines Sales Share by Type (2017-2022)
Table 29. Global Anti-Infective Vaccines Sales Share by Type (2023-2028)
Table 30. Global Anti-Infective Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Anti-Infective Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Anti-Infective Vaccines Revenue Share by Type (2017-2022)
Table 33. Global Anti-Infective Vaccines Revenue Share by Type (2023-2028)
Table 34. Anti-Infective Vaccines Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Anti-Infective Vaccines Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)
Table 37. Global Anti-Infective Vaccines Sales by Application (2023-2028) & (Units)
Table 38. Global Anti-Infective Vaccines Sales Share by Application (2017-2022)
Table 39. Global Anti-Infective Vaccines Sales Share by Application (2023-2028)
Table 40. Global Anti-Infective Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Anti-Infective Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Anti-Infective Vaccines Revenue Share by Application (2017-2022)
Table 43. Global Anti-Infective Vaccines Revenue Share by Application (2023-2028)
Table 44. Anti-Infective Vaccines Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Anti-Infective Vaccines Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)
Table 47. North America Anti-Infective Vaccines Sales by Type (2023-2028) & (Units)
Table 48. North America Anti-Infective Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Anti-Infective Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)
Table 51. North America Anti-Infective Vaccines Sales by Application (2023-2028) & (Units)
Table 52. North America Anti-Infective Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Anti-Infective Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Anti-Infective Vaccines Sales by Country (2017-2022) & (Units)
Table 55. North America Anti-Infective Vaccines Sales by Country (2023-2028) & (Units)
Table 56. North America Anti-Infective Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Anti-Infective Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)
Table 59. Europe Anti-Infective Vaccines Sales by Type (2023-2028) & (Units)
Table 60. Europe Anti-Infective Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Anti-Infective Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)
Table 63. Europe Anti-Infective Vaccines Sales by Application (2023-2028) & (Units)
Table 64. Europe Anti-Infective Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Anti-Infective Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Anti-Infective Vaccines Sales by Country (2017-2022) & (Units)
Table 67. Europe Anti-Infective Vaccines Sales by Country (2023-2028) & (Units)
Table 68. Europe Anti-Infective Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Anti-Infective Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)
Table 71. Asia Pacific Anti-Infective Vaccines Sales by Type (2023-2028) & (Units)
Table 72. Asia Pacific Anti-Infective Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Anti-Infective Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)
Table 75. Asia Pacific Anti-Infective Vaccines Sales by Application (2023-2028) & (Units)
Table 76. Asia Pacific Anti-Infective Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Anti-Infective Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Anti-Infective Vaccines Sales by Region (2017-2022) & (Units)
Table 79. Asia Pacific Anti-Infective Vaccines Sales by Region (2023-2028) & (Units)
Table 80. Asia Pacific Anti-Infective Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Anti-Infective Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)
Table 83. Latin America Anti-Infective Vaccines Sales by Type (2023-2028) & (Units)
Table 84. Latin America Anti-Infective Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Anti-Infective Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)
Table 87. Latin America Anti-Infective Vaccines Sales by Application (2023-2028) & (Units)
Table 88. Latin America Anti-Infective Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Anti-Infective Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Anti-Infective Vaccines Sales by Country (2017-2022) & (Units)
Table 91. Latin America Anti-Infective Vaccines Sales by Country (2023-2028) & (Units)
Table 92. Latin America Anti-Infective Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Anti-Infective Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Anti-Infective Vaccines Sales by Type (2017-2022) & (Units)
Table 95. Middle East and Africa Anti-Infective Vaccines Sales by Type (2023-2028) & (Units)
Table 96. Middle East and Africa Anti-Infective Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Anti-Infective Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Anti-Infective Vaccines Sales by Application (2017-2022) & (Units)
Table 99. Middle East and Africa Anti-Infective Vaccines Sales by Application (2023-2028) & (Units)
Table 100. Middle East and Africa Anti-Infective Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Anti-Infective Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Anti-Infective Vaccines Sales by Country (2017-2022) & (Units)
Table 103. Middle East and Africa Anti-Infective Vaccines Sales by Country (2023-2028) & (Units)
Table 104. Middle East and Africa Anti-Infective Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Anti-Infective Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 106. Emergent BioDefense Operations Lansing Inc. Corporation Information
Table 107. Emergent BioDefense Operations Lansing Inc. Description and Major Businesses
Table 108. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Emergent BioDefense Operations Lansing Inc. Recent Developments
Table 111. Sanofi Pasteur Corporation Information
Table 112. Sanofi Pasteur Description and Major Businesses
Table 113. Sanofi Pasteur Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Sanofi Pasteur Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Sanofi Pasteur Recent Developments
Table 116. Merck & Co. Corporation Information
Table 117. Merck & Co. Description and Major Businesses
Table 118. Merck & Co. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Merck & Co. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Merck & Co. Recent Developments
Table 121. MedImmune LLC Corporation Information
Table 122. MedImmune LLC Description and Major Businesses
Table 123. MedImmune LLC Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. MedImmune LLC Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. MedImmune LLC Recent Developments
Table 126. Novartis Vaccines Corporation Information
Table 127. Novartis Vaccines Description and Major Businesses
Table 128. Novartis Vaccines Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Novartis Vaccines Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Novartis Vaccines Recent Developments
Table 131. Diagnostics Ltd. Corporation Information
Table 132. Diagnostics Ltd. Description and Major Businesses
Table 133. Diagnostics Ltd. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Diagnostics Ltd. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Diagnostics Ltd. Recent Developments
Table 136. Intercell Biomedical Corporation Information
Table 137. Intercell Biomedical Description and Major Businesses
Table 138. Intercell Biomedical Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Intercell Biomedical Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Intercell Biomedical Recent Developments
Table 141. MassBiologics Corporation Information
Table 142. MassBiologics Description and Major Businesses
Table 143. MassBiologics Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. MassBiologics Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. MassBiologics Recent Developments
Table 146. Barr Labs, Inc. Corporation Information
Table 147. Barr Labs, Inc. Description and Major Businesses
Table 148. Barr Labs, Inc. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Barr Labs, Inc. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Barr Labs, Inc. Recent Developments
Table 151. Organon Teknika Co. Corporation Information
Table 152. Organon Teknika Co. Description and Major Businesses
Table 153. Organon Teknika Co. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Organon Teknika Co. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Organon Teknika Co. Recent Developments
Table 156. GlaxoSmithKline Biologicals Corporation Information
Table 157. GlaxoSmithKline Biologicals Description and Major Businesses
Table 158. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. GlaxoSmithKline Biologicals Recent Developments
Table 161. CSL Ltd. Corporation Information
Table 162. CSL Ltd. Description and Major Businesses
Table 163. CSL Ltd. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 164. CSL Ltd. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. CSL Ltd. Recent Developments
Table 166. ID Biomedical Co. Corporation Information
Table 167. ID Biomedical Co. Description and Major Businesses
Table 168. ID Biomedical Co. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 169. ID Biomedical Co. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. ID Biomedical Co. Recent Developments
Table 171. Protein Sciences Co. Corporation Information
Table 172. Protein Sciences Co. Description and Major Businesses
Table 173. Protein Sciences Co. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 174. Protein Sciences Co. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Protein Sciences Co. Recent Developments
Table 176. Wyeth Pharmaceuticals, Inc. Corporation Information
Table 177. Wyeth Pharmaceuticals, Inc. Description and Major Businesses
Table 178. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 179. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
T
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs